11/22
08:42 am
vrpx
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™ [Yahoo! Finance]
High
Report
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™ [Yahoo! Finance]
11/22
08:30 am
vrpx
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™
High
Report
Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™
11/21
04:05 pm
vrpx
Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
High
Report
Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
11/18
10:28 am
vrpx
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering [Yahoo! Finance]
High
Report
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering [Yahoo! Finance]
11/18
10:23 am
vrpx
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering
Medium
Report
Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering
11/15
04:16 pm
vrpx
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
High
Report
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
11/15
04:09 pm
vrpx
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
High
Report
Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
11/13
09:15 am
vrpx
Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Medium
Report
Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants